Menu Search
Equities

Nutex Health Inc

NUTX:NAQ

Nutex Health Inc

Actions
TechnologyTechnology
  • Price (USD)25.17
  • Today's Change0.31 / 1.25%
  • Shares traded94.39k
  • 1 Year change-21.22%
  • Beta0.0859
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Nutex Health Inc grew revenues 12.93% from 219.29m to 247.65m while net income improved from a loss of 424.78m to a smaller loss of 45.79m.
Gross margin19.21%
Net profit margin-10.79%
Operating margin-7.33%
Return on assets-6.93%
Return on equity-48.78%
Return on investment-8.57%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Nutex Health Inc fell by 12.25m. However, the company earned 1.26m from its operations for a Cash Flow Margin of 0.51%. In addition the company used 11.24m on investing activities and also paid 2.27m in financing cash flows.
Cash flow per share-2.45
Price/Cash flow per share--
Book value per share12.58
Tangible book value per share6.54
More ▼

Balance sheet in USDView more

Nutex Health Inc has a Debt to Total Capital ratio of 76.83%, a lower figure than the previous year's 265.15%.
Current ratio1.59
Quick ratio1.55
Total debt/total equity4.33
Total debt/total capital0.7683
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.